Reactive Doses and Times During Oral Food Challenge to Peanut
- Conditions
- Peanut Allergy
- Registration Number
- NCT03852342
- Lead Sponsor
- University Hospital, Montpellier
- Brief Summary
- Peanut allergy is a growing public health problem in developed countries with more and more hospitalizations for anaphylaxis. It has been determined that sensitization to certain peanut proteins such as rAra h 2, is predictive of allergy and could predict the severity of reaction (anaphylaxis) during Oral food challenges (OFC). So far, consensual threshold for cutaneous test and IgE as predictor in the positivity of OFC have not been determined. Identification of reactive doses for OFC and phenotype of patients would help to personalize management of patients subgroups, with an optimal security. 
- Detailed Description
- Not available 
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 262
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
- Name - Time - Method - Reactive doses of peanut (mg) at which an allergic reaction appears in patients with positive peanut Oral Food Challenge - 1 day - An Oral Food Challenge consists in the ingestion of the suspected allergic food. The patient is given increased dose levels of this food throughout a day. The OFC is positive when the patient presents a clinical reaction (clinical symptoms linked to an allergic response) triggered by the food ingested. 
 We'll gather the data of all patients who came in our unit of Allergology and who had a positive peanut OFC.
 The reactive dose is calculated from the total cumulative dose (mg) of peanut reached when the OFC peanut is considered positive.
 The reactive dose is considered as a time dependent data and will be analyzed with survival data analysis methods.
 The analyzed event is a positive OFC
- Secondary Outcome Measures
- Name - Time - Method - Identifying risk factors of peanut hypersensitivity - 1 day - To identify the risk factors, that remain significantly associated with a positive peanut OFC - Time between the reaction and the last administered dose - 1 day - Time between the reaction and the last administered dose - Risk factors of anaphylaxis during a positive peanut OFC - 1 day - To identify, among the collected data on the patient's clinical history detailled below, the risk factors of occurrence of an anaphylactic reaction during peanut OFC. 
 Anaphylaxis is defined as a severe allergic reaction that appears quickly and has a fatal potential. It is usually characterized by the appearance of several signs and symptoms that can affect one or more systems of our body.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
- University hospital of Montpellier 🇫🇷- Montpellier, France University hospital of Montpellier🇫🇷Montpellier, France
